LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 32.60 | 27.76 | 1183 | 2235 | 0.5291 | 0.8087 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.01 | 27.76 | 120 | 2662 | 0.0451 | 0.2490 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 36.01 | 27.76 | 1216 | 2662 | 0.4566 | 0.7755 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 37.71 | 27.76 | 1306 | 2877 | 0.4538 | 0.7774 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 39.41 | 27.76 | 151 | 3105 | 0.0486 | 0.2826 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 1.95 | 27.76 | 627 | 225 | 2.7849 | 1.8075 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 3.66 | 27.76 | 718 | 283 | 2.5288 | 1.6372 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 5.36 | 27.76 | 3 | 320 | 0.0094 | -0.4677 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.06 | 27.76 | 868 | 360 | 2.4111 | 1.5376 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 8.76 | 27.76 | 5 | 401 | 0.0125 | -0.3591 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 11 | 438 | 0.0251 | -0.2074 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 1060 | 438 | 2.4165 | 1.4961 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.87 | 27.76 | 1065 | 604 | 1.7612 | 1.2716 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 15.58 | 27.76 | 24 | 685 | 0.0350 | -0.0310 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 26 | 838 | 0.0310 | -0.0132 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 1157 | 838 | 1.3795 | 1.1352 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 58 | 1119 | 0.0518 | 0.1482 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 20.68 | 27.76 | 1157 | 1119 | 1.0340 | 1.0126 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 22.39 | 27.76 | 1167 | 1305 | 0.8938 | 0.9600 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 24.09 | 27.76 | 70 | 1461 | 0.0479 | 0.1756 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 27.49 | 27.76 | 1114 | 1723 | 0.6465 | 0.8588 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 29.19 | 27.76 | 98 | 1863 | 0.0526 | 0.2310 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.81 | 27.76 | 1286 | 3596 | 0.3576 | 0.7274 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 42.81 | 27.76 | 136 | 3596 | 0.0378 | 0.2541 | MN20160318_Q01 | N22 |